Carl L. Gordon, Director, 10% Owner at Theseus Pharmaceuticals, Inc. (THRX), bought 959,864 shares at $3.05 ($2.9M) on 2023-07-17, disclosed to the SEC on 2023-07-19.
Open-market purchase of $2.9M THRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.05 | 151,450 | $462K | 15.8% |
| 2 | $3.05 | 151,450 | $462K | 15.8% |
| 3 | $3.05 | 328,482 | $1.0M | 34.2% |
| 4 | $3.05 | 328,482 | $1.0M | 34.2% |
| Total | $3.05 avg | 959,864 | $2.9M | 100% |
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |